June 2016


NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Ongoing All Ranks Non-federal Culture of Health

Robert Wood Johnson Foundation (RWJF)
Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Development of data and evidence needed to advance a Culture of Health.  Research could:
(1) Provide evidence for factors in the Action Framework that are believed - but not yet proven to impact health; (2) Reframe or challenge existing ideas; (3) Integrate existing data and methods across disciplines and sectors; and/or (4) Identify actions that can improve health for marginalized populations.
Due Dates: Applicants can expect notification w/in 6-8 weeks of a 2-page Letter of Intent submission. Invited applicants will have 2 months to submit a proposal. Funding decisions will generally be made within 6-8 weeks of the full submission.
Amount & Project Period: ~$200,000 - up to 30 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι 2015 Call For Proposals

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03


Ongoing All Ranks Federal See BAA

United States Army Medical Research and Materiel Command (USAMRMC) Broad Agency Announcement for Extramural Medical Research
W81XWH-16-R-BAA1

The mission of the USAMRMC is to provide solutions to medical problems of importance.  Projects must be for basic and applied research. Projects must be for scientific study and experimentation directed toward advancing the state of the art or increasing knowledge or understanding.  (See general description of research and development programs, including research areas of interest in the announcement.)
Due Dates: Open continuously from Oct. 01, 2015 through Sept. 30, 2016. Organizations are required to submit pre-proposals/pre-applications. 
Amount & Project Period: Budgets are not limited - up to 5 years
Eligibility: All individuals, regardless of ethnicity, nationality, or citizenship status, employed by, or affiliated with, an eligible organization.
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-16-R-BAA1


Rolling All Ranks Non-federal Pediatric

Thrasher Research Fund
E.W. "Al" Thrasher Awards

Ideal applications address significant health problems that affect children in large numbers and offer the potential for practical solutions to these problems.  Such solutions sh/be innovative and have potential for broad applicability w/low financial and/or technical barriers to implementation.  Hypothesis-driven research is preferred over exploratory, hypothesis-generating research. Projects with a shorter distance to clinical applicability are given priority.
Due Dates: Concept papers accepted on a rolling basis, and time from submission to decision is 1-6 weeks.  Submission of full proposal is allowed up to 1 year after approval of concept.  Review and response on proposal can take about 4 months.  Proposals and reviews are submitted to Committees at the beginning of Feb. and Aug. and final decisions are made in late Mar. and late Sept. 
Amount & Project Period: Grant amount is based on the actual budgetary needs of the project - Up to 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Guidance


NEW
May 24 (LOI) All Ranks Federal Hispanic Health Services

Department of Health and Human Services
Centers for Medicare & Medicaid Services
Center for Medicare & Medicaid Innovation
Grants to Support the Hispanic Health Services Research Grant Program

This FOA seeks competitive applications for small applied research projects that relate to identifying and evaluating solutions for eliminating health disparities among Hispanics. Researchers are expected to become involved in the design, implementation, and operation of research projects that address health care issues such as financing, delivery, access, quality, and barriers affecting the Hispanic community.
Due Dates: May 24 (Letter of Intent)
Applications Due:  June 27 (OSR) I June 29 (Sponsor)
Amount & Project Period: $215,000 (Total) - 2 years
NOTE:  CMS requires cost sharing equal to at least 1% of the award amount.   Applications that do not include cost sharing will not be considered for further review.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: CMS-1H0-16-001


May 24 (LOI) All HOPA Members Non-federal Hematology/Oncology Pharmacy

The Hematology/Oncology Pharmacy Association (HOPA) Foundation
2016 HOPA Research Fund Award

To support a hematology/oncology pharmacy practice research project with subsequent publication.   Pharmacy practice is broadly defined including areas such as outcomes, surveys, patient safety, standards validation, and translational science applications. Multiple institutions may be involved in the project, and co-PI projects are allowed.
Due Dates: May 24 (Letter of Intent)
Invited Applications:  Sept. 01 (OSR) Ι Sept. 05 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: Open to all HOPA members
Contact: Office of Sponsored Research (x6804)
Link: 2016 HOPA Research Fund Award
U01 NCI

May 24 (LOI) All Ranks Federal Clinical Assay Development

Integrating Biospecimen Science Approaches into Clinical Assay Development

This FOA will support extramural research to investigate and mitigate challenges facing clinical assay development due to biopsy biospecimen pre-analytical variability. The program will tie in with current efforts to optimize clinical biomarker assays utilized in NCI-sponsored clinical trials. 
Due Dates: May 24 (Letter of Intent)
Applications: June 20 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: Limited to $250,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks - A multidisciplinary research team is encouraged.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-166
R25 NCI
Cycle II Due Date
May 25 Associate/Full Members Federal Cancer Education

Cancer Education Grants Program  Curriculum or Methods Development

This FOA will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications that propose innovative, state-of-the-art programs, addressing the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients are encouraged.
Due Dates: May 23 (OSR) Ι May 25 (Sponsor)
Additional 2016 Due Date:  Sept. 25
Amount & Project Period: $100,000/year (Direct Costs) - 3 years
Eligibility: Established investigator at Associate Professor level or above in scientific area in which application is targeted, and capable of providing both administrative and scientific leadership to development and implementation of proposed program.
PD(s)/PI(s) with a currently funded NCI R25 award may submit an additional application in response to this FOA only if a new and innovative course that is distinctly different from the currently funded project is proposed.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-150
Companion FOAs: PAR-15-151, R25-Cancer Research Education Grants Program: Courses for Skills Development
PAR-15-152, R25-Cancer Research Education Grants Program:  Research Experiences
T32 NIH
NCI is a participating Institute
May 25 All Faculty federal Career Development

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant

Training grants enhance pre and postdoctoral research training, including short-term research training, and help ensure a diverse and highly trained workforce.  Training programs will incorporate didactic, research, and career development components.
Due Dates: May 23 (OSR) Ι May 25 (Sponsor)
Additional Due Dates:  Standard Dates
Amount & Project Period: Awards provide stipends for trainees, contribute to the cost of tuition & fees for trainees, and training-related expenses for trainees - 5 years
Eligibility: All Faculty - PD/PI should be an established investigator in scientific area in which application is targeted and capable of providing both administrative and scientific leadership to development and implementation of proposed program.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-152
U01 NCI

May 25 (LOI) All Ranks Federal Cancer Systems Biology

Emerging Questions in Cancer Systems Biology

This FOA solicits well-defined, discrete and circumscribed Research Projects addressing emerging problems in cancer as a part of a new Cancer Systems Biology Consortium (CSBC).  The consortium will include U54 CSBC Research Centers and a U24 CSBC Coordinating Center (see companion opportunities below). The CSBC initiative aims to address challenges in cancer Research through the use of experimental biology or population science combined with in silico modeling, multi-dimensional data analysis , and systems engineering.
Due Dates: May 25 (Letter of Intent)
June 22 (OSR) Ι June 24 (Sponsor)
Additional 2016 Due Date: Nov. 18
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks 
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-131
Companion Opportunities: RFA-CA-15-014 U54 Research Centers for Cancer Systems Biology Consortium
RFA-CA-15-015 U24 Coordinating Center for the Cancer Systems Biology Consortium and the Physical Sciences-Oncology Network


Deadline Extended
May 26 Postdocs/Junior Faculty Non-federal Women's Lung

 American Lung Association and Bonnie J. Addario Lung Cancer Foundation
2016 Momentum Research Award: Defeating Lung Cancer in Women

This award will support novel, innovative and transformative research with potential of high clinical impact in the early detection of lung cancer in women, as well understanding gender differences in lung cancer incidence, pathophysiology, treatment outcomes, and prognoses, etc.
Due Dates: May 24 (OSR) Ι May 26 (Sponsor)
Amount & Project Period: $250,000 - 2 years
Eligibility: Applicants (MD/PhD/ MD, PhD) must be w/in 5 years of first faculty appointment as of May 26, 2016.
Applicants not holding a faculty appointment, but having completed 2 years of fellowship/post-doctoral training and on track for faculty appointments are eligible.
Contact: Office of Sponsored Research (x6071)
Link: ProposalCENTRAL
R01 NCI

May 30 (LOI) All Ranks Federal NCI Provocative Questions

Revision Applications to R01 Awards for Research on the NCI's Provocative Questions

This FOA invites revision applications from PIs w/active NIH R01 grants.  Applications must focus on research related to one of the Provocative Questions (PQs) published for new applications in RFA-CA-15-008 and RFA-CA-15-009.  Research is encouraged that directly addresses PQs, including research that helps validate PQ research outcomes or adopts and disseminates PQ research results that impact cancer research and clinical care. Studies proposed must correspond to additional specific aims, expanding the scope of individual, already funded projects of the parent R01 award.
Due Dates: May 30 (Letter of Intent)
June 24 (OSR) Ι June 28 (Sponsor)
Additional Due Date:  Oct. 28
Amount & Project Period: $150,000/yr. (Direct Costs) - up to 2 years
Eligibility: All Ranks
PD/PI (or Contact PD/PI for MPI awards) on parent award must be the same on revision application.
R01 research grants w/at least 2 years remaining at time of award.
Application must specifically address a particular scientific problem identified as one of the PQs exactly as defined in this FOA
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-16-010
Companion RFAs: RFA-CA-16-011, Revision Applications to U01 Awards for Research on the NCI's Provocative Questions
RFA-CA-16-013, Revision Applications to P01 Awards for Research on the NCI's Provocative Questions
RFA-CA-16-012, Revision Applications to P50 Awards for Research on the NCI's Provocative Questions


May 31 ALL Ranks Non-federal Culture of Health

Robert Wood Johnson Foundation
Global Ideas for U.S Solutions

Looking for projects, programs, and models that promote health equity and are aligned with our Culture of Health Action Framework; current year interests in ideas that: Build healthy places; Build social connection across the lifespan; Get and keep children healthy; Integrate health and social services; and Increase the health care system's focus on the root causes of poor health.
Due Dates: May 27 (OSR) I May 31 (Sponsor)
Amount & Project Period: $50,000 up to $250,000 -  up to 18 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Guidelines
U01 NCI

May 31 (LOI) All Ranks Federal Combined Modality Treatment
 of Solid Tumors

Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy

For studies to enhance pre-clinical in vitro and in vivo testing of NCI-prioritized molecularly targeted anti-cancer agents for use with radiation therapy combined with systemic chemotherapy. The overall goal is to accelerate the pace at which combined modality treatments with greater efficacy are identified and incorporated into standard practices for treatments of patients with solid tumors.
Due Dates: May 31 (Letter of Intent)
Full Applications: Jul. 12 (OSR) Ι Jul. 14 (Sponsor)
Additional Due Dates: Dec. 14; Jul 14 & Dec. 14, 2017
Amount & Project Period: Not to exceed $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-111
R21 NCI

NEW
May 31 (LOI) All Ranks Federal Pediatric Provocative Questions

Research Answers to NCI's Pediatric Provocative Questions

The purpose of this FOA is to invite applications for research projects designed to use sound and innovative strategies to solve specific problems and paradoxes in childhood cancer research identified by the National Cancer Institute (NCI) as the NCI's Pediatric Provocative Questions (Pediatric PQs).
Due Dates: May 31 (Letter of Intent)
June 28 (OSR) Ι June 30 (Sponsor)
Additional 2016 due date:  Nov. 24
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-217
Companion FOA: PAR-16-218, R01 Research Project Grant



NEW
June 01 Postdocs/Junior Faculty Federal Career Development

The Air Force Research Laboratory (AFRL)
Air Force Office of Scientific Research (AFOSR)
Air Force Fiscal Year 2017 Young Investigator Research Program (YIP)
BAA-AFRL-AFOSR-2016-0006

The objective of this program is to foster creative basic research in science and engineering; enhance early career development of outstanding young investigators.  See areas of interest identified in the most recent Broad Agency Announcement titled "Research Interests of the Air Force Office of Scientific Research"
Due Dates: May 27 (OSR) Ι June 01 (Sponsor)
All technical or general pre-proposal inquiries & questions must be submitted by Monday, May 2nd.
Amount & Project Period: $120,000/yr. (Total) - 3 years
Eligibility: Scientists who have received PhD or equivalent degrees 4/01/2011 or later
Must hold full-time permanent, career-competitive, or tenure-track position, or 
Proposal must include a letter from organization confirming consideration for such an appointment.
Must be a U.S. citizen, national, or permanent resident.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι BAA-AFRL-AFOSR-2016-0006


June 01 All Faculty Non-federal Treatments & Cures

Elsa U. Pardee Foundation
Cancer Research

The Foundation supports research directed toward identifying new treatments or cures for cancer.  It  encourages  applications which will allow establishment of capabilities of new cancer researchers,  or new cancer approaches by established cancer researchers.
Due Dates: May 27 (OSR) Ι June 01 (Sponsor)
Additional 2016 Due Date:  Oct. 01
Amount & Project Period: Amount varies, dependent on project  - 1 year
Eligibility: All Faculty
Contact: Office of Sponsored Research  (x6804)
Link: Grant Application Process

and


June 02 All Ranks Non-federal Pediatric Brain Cancer

The Cure Starts Now Foundation
Research Grants

Funds search for a cure for brainstem glioma and other forms of pediatric brain cancer in the hopes of curing all cancers Focus is on Diffuse Intrinsic Brainstem Glioma (DIPG), and to support translational and clinical research projects in those areas.
Due Dates: May 30 (OSR) Ι June 01 (Sponsor) Ι Hardcopy due June 05
Amount & Project Period: $100,000 (TOTAL) - 1 year
Eligibility: All Ranks
Contact: Mary Newton (x3658) for writing assistance. 
All completed applications must be approved and submitted through the Office of Sponsored Research (x6804).
Links: Research & Grants
Grant Application Information
Electronic Submission

June 03, 4:00pm Staff/Research Scientists & All Faculty Moffitt Core Projects

Innovative Core Projects Award

The Innovation and Technology Committee (ITC), co-chaired by Dr. Mule and Dr. Koomen, is pleased to announce the Innovative Core Projects Funding Opportunity. With a goal to enhance our institutional innovation, this award is meant to encourage early access to novel technologies before commercially available and further Moffitt's efforts to remain on the forefront of discovery.
Due Dates: June 03 (4:00pm)  All applications along with the Institutional Proposal Submission Form must be submitted to the Office of Sponsored Research for review two days prior to the application due date.
Amount & Project Period: $60,000 - 12 months
Eligibility: This funding opportunity is open to Moffitt faculty as well as Staff Scientists and Research Scientists.
Contact: Brittany Palermo (x1536)
Links: Innovative Core Projects Funding Guidelines  Ι  Face Page
R01 NIH

Parent R01
June 06 All Ranks Federal Research Projects

NIH Research Project Grant

The current Parent R01 expires May 10, 2016 and is replaced by PA-16-160.  The earliest submission date is May 05, 2016.
Due Dates: June 02 (OSR) Ι June 06 (Sponsor)
Additional Due Dates:  Standard Dates Apply
Amount & Project Period: Modular Budget:  $250,000/yr. (Direct Costs) - 5 years
Detailed Budget:  Not Limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-160
R01 NIDCR

June 06 All Ranks Federal Immune System Plasticity

Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases

The purpose is to encourage research projects elucidating the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases.
The goal is to advance knowledge of the immunological basis of dental, oral, and craniofacial diseases, and to develop tools and technologies for precise modulation of the immune system to restore or maintain health.
The expectation is that new knowledge derived from this research will facilitate development of novel immunomodulatory therapies to prevent disease onset or reverse disease progression.
Due Dates: June 02 (OSR) Ι June 06 (Sponsor)
Additional Due Dates:
Standard Dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-192
Companion FOA: PAR-15-193 (R21) Exploratory/Developmental Grant
R01 NCI
June 06 All Ranks Federal See FOAs Below

National Cancer Institute FOAs for Cycle II Due Date

A listing of some new and repeating funding opportunity announcements from NCI.

Due Dates: June 03 (OSR) Ι June 06 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Budget not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival

This FOA encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival.
FOA Link: PAR-16-122
Companion FOA: PAR-16-123 (R21)

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment

Applications are encouraged from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.  Partnership on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate their system to solve their chosen cancer problem.  FOA will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work.
FOA Link: PAR-15-075

Early-life Factors and Cancer Development Later in Life

Supports research focused on role of early-life factors in cancer development later in life.  It is necessary to better understand:
   1) Early-life (maternal-paternal, in utero, birth and infancy, puberty and adolescence, and teenage and young adult years) factors associated with later cancer development;
   2) How early-life factors mediate biological processes relevant to carcinogenesis; and
   3) Whether predictive markers for cancer risk based on what happens biologically at early-life can be measured and developed for use in cancer prevention strategies.
FOA Link: PA-15-126
Companion FOAs: PA-15-125, R21 Exploratory/Developmental Grant
PA-15-124, R03 Small Grant Program
R01 NIH
NCI is a participating Institute
June 06 All Ranks Federal See FOAs Below

NIH Funding Opportunity Announcements where NCI is a participating institute for Cycle II Due Date

Due Dates: June 02 (OSR) Ι June 06 (Sponsor) Additional Due Dates:  Standard Dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)


Population Health Interventions: Integrating Individual and Group Level Evidence

The purpose of this FOA is to support multilevel, transdisciplinary population health interventions that target underlying social, economic, and environmental conditions in an effort to improve health outcomes.
FOA Link: PA-16-146
Companion FOA: PA-16-147 (R21)

Obesity Policy Evaluation Research

This FOA encourages applications that propose to evaluate policies or large scale programs that are expected to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes have the potential to prevent or reduce rates of obesity.  NCI is particularly interested in the evaluation of programs or policies that may affect dietary or physical activity behavior and/or weight, and studies incorporating economic research.
FOA Link: PA-16-165
 

Diet and Physical Activity Assessment Methodology

The overarching goal is to provide support to promote  early and conceptual stages of research efforts on novel scientific ideas having potential to substantially advance cancer research, such as improving epidemiologic study data collection; validating measurement of exposures in body fluids and tissues; applying epigenetic or metabolomic approaches to cancer epidemiology research; developing and applying novel strategies for discovery of risk variants for rare cancers; understanding the population genetic architecture of cancer in understudied populations; or validating methods to extract, collect, and synthesize clinical data via electronic medical records for use in observational studies of cancer patients and survivors.
FOA Link: PA-16-167
Companion FOA: PAR-15-171 (R21 Exploratory/Developmental Grant)

The Health of Sexual and Gender Minority (SGM) Populations

This FOA calls for research on the health of lesbian, gay, bisexual, transgender, intersex, and related populations. 
FOA Link: PA-15-261
Companion FOAs: PA-15-263, R21 Exploratory/Developmental Grant
PA-15-262, R03 Small Grant Program
PA-15-260, R15 Academic Research Enhancement Award (AREA)  

Bioengineering Research Grants (BRG)

This FOA encourages collaborations between life and physical sciences that:  1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate adoption of promising tools, methods and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. 
FOA Link: PAR-16-242

Mechanisms, Models, Measurement, & Management in Pain Research

The purpose of this FOA to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of the participating centers and institutes.  Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators.
FOA Link: PA-16-188
Companion FOA: PA-16-187 (R21)
 

The Role of Mobile Genetic Elements in Cancer

This FOA encourages applications to investigate mechanisms regulating the expression and activity of mobile genetic elements, including long terminal repeat (LTR) and non-LTR retroelements, in cancer.  The FOA seeks proposals that specifically investigate mechanisms regulating the expression and activity of mobile genetic elements in the context of cell transformation and assess the impact of their activity on tumor heterogeneity, cancer evolution, and response to therapy.
FOA Link: PAR-16-226
Companion FOA: PAR-16-227 (R21)
 

Dissemination and Implementation Research in Health

This FOA encourages research applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.
FOA Link: PAR-16-238
Companion FOAs: PAR-16-236 (R21) Ι  PAR-16-237 (R03)


June 06 All Faculty Non-federal Translational Research

The Harrington  Discovery Institute
Scholar-Innovator Award

This Award recognizes physician-scientist innovators throughout the U.S. whose research has the potential to change standard of care. The Scholar-Innovator Award provides research and drug development funding as well as non-financial support to selected innovators and their institutions to help bridge the gap between basic discovery and clinical introduction.
Due Dates: June 2 (OSR) Ι June 6 (Sponsor)
Submissions will be completed online at HarringtonDiscovery.SmartSimple.com
Amount & Project Period: $100,000  - 1 year.   See program description for additional information
Eligibility: Hold an MD or MD/PhD;
Hold a faculty position;
May have only a single PI;
Past recipients of the Harrington Scholar-Innovator Awards may submit new & distinct proposal but may not seek additional support for previously funded projects.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Grant Program Details Ι Program Policies


NEW
June 08 (Pre-app.) Established Investigators Federal Neurofibromatosis

Congressionally Directed Medical Research Programs
Neurofibromatosis Research Program (NFRP)  
Clinical Consortium Award W81XWH-16-NFRP-CCA

Will support a Consortium of exceptional institutions and investigators that will accelerate clinical translation of basic NF research and ultimately decrease impact of the disease.  The Consortium shall consist of one central Operations Center that will be responsible for facilitating the rapid selection, design, execution and analysis of clinical trials within the Consortium.  The Consortium shall consist of a minimum of 5 Clinical Trial Sites necessary to effectively participate in multiple trials. All sites must be identified, have clinical trials experience, and multidisciplinary expertise in supporting NF1 and/or NF2 and/or schwannomatosis clinical research.
Due Dates: June 08 (Pre-application)
Invited Submissions:  Jul. 28 (OSR) Ι Aug. 01  (Sponsor)
Amount & Project Period: $5,000,000 (Direct Costs) - 4 years
Option for 2 additional periods up to $2M (Total Costs) each (contingent upon receipt of future Congressional appropriations) for an additional max. performance period of 4 years
Eligibility: Operations Center PI must be independent investigator at or above Associate Professor (or equiv.) level w/experience in developing and running large scale initiatives such as clinical trials or consortia.
Contact: Office of Sponsored Research (x6804)
Links: FY16 Neurofibromatosis Research Program (NFRP)
Program Announcement
https://eBRAP.org (Pre-app.)


NEW
June 08 (Pre-app.) See Below Federal See Below

Congressionally Directed Medical Research Programs (CDMRP)
Peer Reviewed Cancer Research Program (PRCRP)

Due Dates: June 08 (Pre-application)
Invited Submissions:  Sept. 09 (OSR) Ι Sept. 13 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: PRCRP Programs  Ι  eBRAP (Pre-app.)
 

Career Development Award
W81XWH-16-PRCRP-CDA
 

Supports independent, early-career investigators to conduct impactful research w/mentorship of an experienced cancer researcher.  Application must address at least one of the FY16 PRCRP Topic Areas. Preliminary data not required. Clinical trials are not allowed.
Amount & Project Period: $360,000 (Direct Costs) - 3 years
Eligibility: Principal Investigator (PI): Independent early-career investigator w/in 10 years after completion of terminal degree (excl. time spent in residency or on family medical leave) by application submission deadline;
PI must commit a min. of 30% effort to proposed research. Designated Mentor: Investigators at or above Associate Professor (or equivalent) level; must have a proven publication and funding record in cancer research.
Link: Program Announcement
 

Idea Award with Special Focus
W81XWH-16-PRCRP-IA

Supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research relevant to Service members, their families, and other military beneficiaries.
The "Special Focus" of this award mechanism is on exposures, conditions, or circumstances that are unique to the military, disproportionately represented in a military beneficiary population, or may affect mission readiness.
Amount & Project Period: $400,000 (Direct Costs) - 2 years
Eligibility: Investigator with a faculty-level appointment (or equivalent).
Link: Program Announcement
 

Translational Team Science Award
W81XWH-16-PRCRP-TTSA

Supports hypothesis-driven translational studies associated with an ongoing (not intended to fund ongoing clinical trial) or completed clinical trial that could lead to a next-phase clinical trial or future clinical application. May support preclinical studies in animal models and human subjects and human anatomical substances. Not intended to support high throughput screenings, sequencing, etc.
Amount & Project Period: $1,000,000 (Direct Costs) - 3 years
Eligibility: At least 2 and up to 3 PIs must partner in one overarching correlative or translational research study.
Initiating PI sh/be at or above  Assistant Professor level or equiv.
Partnering PI(s) must be at or above the level of Assistant Professor (or equiv.)
It is encouraged that at least one of the PIs be a military or VA investigator. 
Link: Program Announcement

June 08 (Pre-app.) Postdocs/Fellows Federal Career Development

NIH Director's Early Independence Award (DP5)
Limited Submission - Requires Moffitt pre-application

Opportunity for outstanding  junior investigators to accelerate entry into an independent research career by forgoing traditional post-doctoral training to pursue independent research directly after completion of terminal doctoral degree or clinical residency.
Due Dates: June 08, 4:00pm
(Pre-application to include: 1 page letter of introduction & 2-page research outline submitted electronically to Maureen.ahearn@moffitt.org (PDF format only))
Amount & Project Period: $250,000/yr. (Direct Costs) - 5 years
Eligibility: At time of application, candidate must be w/in 1 year (before or after) of completing a terminal degree or clinical residency, and must not be in an independent position
Contact: Maureen Ahearn (x8824)
RFA Link: RFA-RM-16-006


NEW
June 09 (Pre-app.) See Below Federal Prostate

Congressionally Directed Medical Research Programs (CDMRP)
Prostate Cancer Research Program (PCRP)

Due Dates: June 09 (Pre-application)
Invited Submissions:  Aug. 23 (OSR) Ι Aug. 25 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: FY16 Prostate Cancer Research Program (PCRP) https://eBRAP.org (Pre-app.)
 

Health Disparity Research Award
W81XWH-16-PCRP-HDRA

This award supports new ideas based on innovative concepts or methodologies for health disparity research with potential to make an important contribution toward eliminating death from prostate cancer.   Studies are expected to improve understanding of, and ultimately contribute to eliminating disparities in prostate cancer incidence, morbidity, mortality, and survivorship.  Applicants for this award must explicitly state how the proposed research is related to an area of prostate cancer health disparity.
Amount & Project Period: Standard Award:                         $450,000 (Direct Costs)
Qualified Collaborator Option: $600,000 (Direct Costs)
Nested Young Investigator Option: Additional $92,500 (predoctoral) or $115,000 (postdoctoral)
Performance Period:  3 years
Eligibility: Established Investigator Category:  independent investigator at or above the level of Assistant Professor (or equiv.)
New Investigator Category:  must meet the following criteria at application submission deadline:
    1. Have freedom to pursue individual aims w/out formal   
    mentorship
    2. Have not previously received a PCRP Health Disparity
    Research Award
    3. Have either completed at least 3 years of postdoctoral
    training or fellowship or are w/in 5 years of having begun
    first independent faculty position (or equivalent)
Qualified Collaborator Option:  Supports a higher level of funding for PIs who include a collaborator (at or above level of asst. professor) that significantly contributes (10%  or more effort  and provides both intellectual input and research resources to the research project such that it could not otherwise be accomplished.
Nested Health Disparity (HD) Young Investigator Option:  Supports predoctoral (who will have successfully completed comprehensive examinations or otherwise met candidacy requirements by March 31, 2017);  postdoctoral trainee (who will have successfully defended a doctoral thesis or possess an M.D., and will have <3 years of postdoc experience by March 31, 2017).
Link: Program Announcement
 

Impact Award
W81XWH-16-PCRP-IA

This award encourages applications specifically focused on scientific and clinical prostate cancer issues, having potential to make a major impact in eliminating death from prostate cancer and enhancing the well-being of men experiencing the impact of the disease.  The intent is to support the full spectrum of research ideas from basic research to clinical trials.  Applicants are highly encouraged to address one of the PCRP overarching challenges, and are expected to address at least one of the PCRP focus areas. 
Amount & Project Period: Individual PIs:                  $750,000 (Direct Costs)
Partnering PI Option:    $2,000,000 (Direct Costs)
Performance Period:    3 years
Eligibility: Independent investigators at or above Assistant Professor (or equiv.) level for single or partnering PI option.
Link: Program Announcement


June 09 (Pre-app.) See Below Federal Lung

Congressionally Directed Medical Research Programs (CDMRP)
Lung Cancer Research Program (LCRRP)

Due Dates: June 09 (Pre-application)
Invited Submissions:  Sept. 12 (OSR) Ι Sept. 14 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: FY16 Lung Cancer Research Program (LCRP)
https://eBRAP.org (Pre-app.)
 

Career Development Award
W81XWH-16-LCRP-CDA

Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher; preliminary data not required.
Amount & Project Period: $250,000 (Direct Costs) - 2 years
Eligibility: Must be independent investigator at level of Assistant Professor, Instructor, or equiv.;
Must be w/in 5 years of first faculty appointment (or equiv.), and exhibit a strong desire to pursue a career in lung cancer research.
Mentor: At or above the level of Associate Professor (or equivalent); have a proven publication and funding record in lung cancer research
Link: Program Announcement
 

Idea Development Award
W81XWH-16-LCRP-IDA

Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research; emphasis on innovation and impact; New Investigator category supports applicants early in their faculty appointments or in the process of developing independent research careers; preliminary data required, but may be from outside of lung cancer.
Amount & Project Period: $350,000 (Direct Costs) - 2 years
Eligibility: Although a PI may be eligible for both the New Investigator and Established Investigator categories, the PI can choose only one category under which to apply.
Established Investigators: Independent investigators at or above the level of Assistant Professor (or equivalent); or
New Investigators: Investigators that meet the following criteria at the application submission deadline date:
     1. Have not previously received a LCRP Idea Development 
     Award or Early Investigator Synergistic Idea Award   
     2. Independent investigators at or above Assistant  
     Professor (or equivalent) and be w/in 10 years of first
     faculty appointment (or equivalent)
Link: Program Announcement
 

Clinical Exploration Award
W81XWH-16- LCRP-CEA

Supports rapid execution of hypothesis-driven, early-phase clinical trials to examine interventions that could have a major impact on lung cancer clinical management. Application must include documentation of an existing Investigational New Drug (IND) or Investigational Device Exemption, if applicable.
Amount & Project Period: $550,000 (Direct Costs) - 3 years
Eligibility: Independent investigators at or above the level of Assistant Professor (or equivalent)
Link: Program Announcement
 

Investigator-Initiated Translational Research Award
W81XWH-16-LCRP-IITRA

Supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Mechanism is intended to fund a broad range of translational studies, including, but not limited to:
     1. Studies advancing/translating in vitro and/or animal studies to applications w/human
     samples/cohorts.
     2. Late-stage preclinical work leading to/preparing for a clinical trial.
     3. Correlative studies associated with an ongoing or completed clinical trial and
     projects that develop endpoints for clinical trials.
Amount & Project Period: $400,000 (Direct Costs) - 2 years
Eligibility: Independent investigators at or above the level of Assistant Professor (or equivalent)
Link: Program Announcement

June 10 Junior Faculty Non-federal Research Support

Vilcek Foundation
The Vilcek Prize for Creative Promise in Biomedical Science

Prizes are awarded to young foreign-born biomedical researchers who demonstrate outstanding early achievement. Eligible work may be in basic, applied, and/or translational biomedical science.
Due Dates: June 08 (OSR) Ι June 10 (Sponsor)
Amount & Project Period: $50,000
Eligibility: Must have been born outside the United States;
Must not be more than 38 years old as of December 31, 2016 (born on or after January 1, 1978);
Must be a naturalized citizen of the United States;
     or be a permanent resident (green card holder) of U.S.
     or be a holder of an H1B or O-1 visa and have been living  
     and working in the U.S. for at least 5 years; or have been
     granted Deferred Action for Childhood Arrivals (DACA); Eligible positions include the following: assistant or associate professor, research scientist, or equiv.;
Must have earned degree (MD, PhD, or equiv.);
Must intend to pursue professional career in U.S.;
Must hold full-time position
Contact: Office of Sponsored Research (x6804)
Links: Vilcek Foundation Ι Guidelines
U01 NCI


 


June 11 (LOI) All Ranks Federal Imaging & Biomarkers

Imaging and Biomarkers for Early Detection of Aggressive Cancer

This FOA invites applications for collaborative research projects to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk and cancer diagnosis aimed at integrating multi-modality imaging strategies and multiplexed biomarker methodologies into a singular complementary approach.
Due Dates: June 11 (Letter of Intent)
Jul. 09 (OSR) Ι Jul. 11 (Sponsor)
Additional Due Date in 2016:  Dec.14
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-089
K01 NLM
National Library of Medicine

Cycle II
New
Submissions
June 13 Junior Faculty Federal Career Development

NLM Career Development Award in Biomedical Informatics and Data Science

The purpose is to provide support for intensive career development in biomedical informatics and data science leading to research independence.   Application domains of interest include health care delivery & consumer health, translation of basic biological research to health outcomes, population medicine & public health, and the organization, analysis and use of biomedical big data.
Due Dates: June 09 (OSR) | June 13 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Up to $100,000 (plus fringe)/yr. for salary
$50,000/yr. for research development costs
Duration:  3 years
Eligibility: Must have research or health-professional doctoral degree or equiv.
Must be w/in 3 years of initial full-time appointment as of submission date.
Must commit 75% effort to career development and research training
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-204
K-Awards NIH

Cycle II
New Submissions
June 13 See Below Federal Career Development

National Research Service Awards (NRSA)

Due Dates: June 09 (OSR) Ι June 13 (Sponsor)
Additional Due Dates: Standard dates
Amount & Project Period: Salary Support:       Up to $100,000 plus fringe benefits/yr. Research Support:  Up to $30,000 per year
Period of Award:     5 years
Eligibility: See Specific FOA and related NCI requirements
Contact: Office of Sponsored Research (x6804)
K99/R00 NIH
NCI is a participating Institute

NIH Pathway to Independence Award

This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions.
Links: PA-16-193 Ι NCI-specific information/requirements
K07 NCI

Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award

The purpose is to support the career development of junior investigators with research or health professional doctoral degrees who want to become cancer-focused academic researchers in cancer prevention, cancer control, or the behavioral or population sciences.
FOA Link: PAR-15-033
K08 NIH
NCI is a participating Institute

Mentored Clinical Scientist Research Career Development Award

The NCI K08 award provides support and "protected time" from clinical duties to non-tenured early career stage clinician-scientists interested in mentored basic and/or translational cancer research.  Eligible candidates must have a clinical degree and perform clinical duties.
Links: PA-16-191 Ι NCI-Specific information/requirements
K22 NCI

The NCI Transition Career Development Award

 The purpose is to facilitate transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning when the candidate starts a tenure-track faculty position.
Amount and Project Period: Salary Support:       Up to $100,000 plus fringe benefits/yr. Research Support:  Up to $50,000/yr.
Period of Award:     5 years
Link: PAR-15-056
Companion FOA: PAR-15-063 (NCI Transition Career Development Award to Promote Diversity)
K23 NIH
NCI is a participating Institute

Mentored Patient-Oriented Research Career Development Award

 The NCI K23 award provides support and "protected time" to non-tenured early career stage clinician-scientists interested in mentored patient-oriented cancer research. Candidates must have a clinical degree and practice clinically.
Links: PA-16-198 Ι NCI-Specific information/requirements
K18 NIDCR

June 13 Established Investigators Federal Career Enhancement

Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators

This FOA encourages applications for short-term mentored career enhancement awards in dental, oral and craniofacial research w/a focus on behavioral and social sciences, and genetic and genomic research.   The intent is to provide mid-career or senior investigators with short-term training in the theories, tools, methods or approaches of another scientific area, in order to enhance their existing research program.
Two categories of candidates are targeted:
      (a) Established dental, oral, and craniofacial research investigators seeking training
      w/investigators from another field, in order to enrich their existing dental, oral and
      craniofacial research program; and
      (b) Established investigators in other fields who seek training with dental, oral and
      craniofacial research investigators in order to facilitate the introduction of dental, oral
      and craniofacial research into an existing research program.
Due Dates: June 09 (OSR) Ι June 13 (Sponsor)
Additional Due Dates: Standard Dates
Amount & Project Period: NIDCR will contribute a min. 20% up to a max. 50%/yr.  to the salary of the career award recipient, and $25,000/yr. toward research development costs.
A project period from 2.5 months to 12 months may be requested
Eligibility: Must have a research or health professional doctoral degree, or a combined health-professional and research doctoral degree.
Intended for well-established investigators at academic rank of Associate Professor or Professor, or equiv., who have established records of independent, peer reviewed Federal or private research grant funding.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-179




NEW
June 13 (LOI) All Ranks Non-federal  Pain Research

American Pain Society and
Pfizer Independent Grants for Learning & Change (IGLC)    
Implementing the National Pain Strategy in an Era of Accountable Care: Improving Chronic Pain Care in America

The purpose of this RFP is to encourage submission of LOIs describing projects designed to address the problems and objectives identified in the National Pain Strategy.  This RFP seeks to fund quality improvement, clinical science and implementation science projects that:
     (a) Translate scientific knowledge into clinically useful approaches that improve the care
     of individuals with chronic pain and that
     (b) Achieve that translation in service of addressing one or more problems and objectives
     identified within the National Pain Strategy's 6 working groups.
Due Dates: June 13 (Letter of Intent)
Invited Submissions:  Sept. 08 (OSR) I Sept. 12 (Sponsor)
Amount & Project Period: Max: $750,000 (Total) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFP
K12 NCI

NEW
June 15 Established Investigators Federal Career Development

Paul Calabresi Career Development Award for Clinical Oncology (PCACO) (NIH Institutional Research Career Development K12 grant mechanism)

This FOA encourages applications for institutional research career development (K12) programs from applicant organizations proposing to promote the training and career development of clinical trials researchers.
Due Dates: June 13 (OSR) Ι June 15 (Sponsor)  
Amount & Project Period: $50,000 (Direct Costs) - year 01 (Curriculum planning and development, advertising and recruiting of the first class of Scholars)
Years' 2-5:  $750,000/yr.  (Direct Costs) - 5 years (Total)
Eligibility: PD/PI sh/be an established investigator in scientific area that application is targeted and capable of providing administrative & scientific leadership to development & implementation of program;
PD/PI will be responsible for selection and appointment of scholars to program, and for overall direction, management, administration, and evaluation of program;
PD(s)/PI(s) are expected to have ongoing R01 and/or R01-like cancer-focused grant support (grants or contracts of at least 3 years' duration and $150,000/yr. direct costs, including those supporting clinical trials.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-189

June 15 Postdocs Non-federal Neurobiology

The International Eppendorf & Science Prize for Neurobiology

An international award which honors young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology.
Due Dates: June 15 (Sponsor)
Amount & Project Period: $25,000 award plus full support to attend the Prize Ceremony held in conjunction with the Annual Meeting of the Society for Neuroscience in the USA and an invitation to visit Eppendorf in Hamburg, Germany
Eligibility: Must be a neurobiologist w/advanced degree received in last 10 years, and not older than 35 years of age.
Entrant's essay must describe contributions to neurobiological research based on methods of molecular and cell biology. Entrant must have performed or directed work described in the essay.
Research must have been performed during the previous three years.
Link: Application Guidelines
R21 NIH

June 16 All Ranks Federal Epidemiology and Genomics

Exploratory Grants in Cancer Epidemiology and Genomics Research

The overarching goal is to provide support to promote  early and conceptual stages of research efforts on novel scientific ideas having potential to substantially advance cancer research, such as improving epidemiologic study data collection; validating measurement of exposures in body fluids and tissues; applying epigenetic or metabolomic approaches to cancer epidemiology research; developing and applying novel strategies for discovery of risk variants for rare cancers; understanding the population genetic architecture of cancer in understudied populations; or validating methods to extract, collect, and synthesize clinical data via electronic medical records for use in observational studies of cancer patients and survivors.
Due Dates: June 14 (OSR) Ι June 16 (Sponsor)
Additional 2016 Due Dates:
  Standard Dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-175
R21 NCI

June 16 All Ranks Federal RBA Modifications in Cancer Biology

Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology

This FOA encourages basic research into the role of RNA chemical modifications and their corresponding writers, readers and erasers in the initiation and progression of cancer.
Due Dates: June 14 (OSR) Ι June 16 (Sponsor)
Additional 2016 Due Dates:  Standard Dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-177





Updated
June 19 Clinical Faculty Non-federal Duvelisib

National Comprehensive Cancer Network® (NCCN®)
Phase I/II Clinical Trials and/or Correlative Studies with Duvelisib for Hematologic Malignancies

The overall aim of the project is to develop innovative studies to help determine the role of duvelisib in the treatment of select hematologic malignancies.  Research emphasis includes 3 areas: 1. Combination Studies to Enhance Efficacy: CLL & iNHL; 2. Concepts Expanding Activity Signal: Rare/Understudied Populations; and 3. Innovative dosing schedules to maximize efficacy & tolerability: CLL & indolent non-Hodgkin lymphoma (iNHL).
Due Dates: June 16 (OSR) Ι June 19 (Sponsor)
Amount & Project Period: Maximum Total Funding:
Phase I and Single-arm Phase II clinical trials:   $300,000
Correlative Lab studies section of clinical trial: $100,000
Multi-institutional funding;                                    $100,000
Period of Performance:   2 years
Eligibility: Clinical Faculty
Contact: Maureen Ahearn (x8824)
Links: RFP Ι Cover Letter Ι NCCN Oncology Research Program


June 20 Faculty Non-federal Women's Cancers

The Foundation for Women's Wellness
Research Awards

These research awards target early funding for small, short-term studies that hold promise for improving medical knowledge in female cancers.  Desired research proposals have direct clinical application in preventing and/or treating disease; studies with the promise of yielding results that will attract larger sources of funding for advancing study; and influencing long-term research directions in its field.
Due Dates: June 16 (OSR) Ι June 20 (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: Must be an M.D. and/or Ph.D. with a faculty appointment (investigator, assistant professor, or higher)
Contact: Office of Sponsored Research (x6804)
Link: Research Awards



NEW
June 21 (Pre-application) Junior Faculty Non-federal Blood-related Cancers

Gabrielle's Angel Foundation for Cancer Research
Mainstream or Conventional Research and Complementary or Integrative Research

Gabrielle's Angel Foundation has announced 2 funding opportunities for cancer research projects for junior faculty who are applying novel and state-of-the-art techniques to address fundamental problems in the genesis and treatment of blood related cancers.  Two proposals may be submitted: 1 in the area of mainstream of conventional research and 1 in complementary or integrative research.
Due Dates: June 21 (Pre-application) Must include a 1 page letter of introduction and a 2-page research outline and be submitted electronically in PDF format only to Maureen Ahearn.  (x8824) Selected Submissions due:  Aug. 10 (OSR) Ι Aug. 12 (Sponsor)
Amount & Project Period: $75,000/yr. (Total) - 3 years
Eligibility: Applicant must have MD or PhD; junior faculty position;  designation of Assistant Professor (Associate Professors may not apply); institutional support in form of tenure track OR be an independent junior faculty member; held current position no longer than 5 years           
Contact: Maureen Ahearn  (x8824)  for additional information
Links: Guidelines Ι Application 
R01 NIH
NCI is a participating institute
June 21 All Ranks Federal Drug Delivery

Image-guided Drug Delivery

Funding will support innovative research projects that are focused on image-guided drug delivery (IGDD), including real-time image guidance, monitoring, quantitative in vivo characterizations and validation of delivery and response.  It will support research in development of integrated imaging-based systems for delivery of drugs or biologics in cancer and other diseases, quantitative imaging assays of drug delivery, and early intervention.
Due Dates: June 19 (OSR) Ι June 21 (Sponsor)
Note: Additional due date in 2016:  Nov. 22
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-044
R21 NCI

June 22 All Ranks Federal Career Development

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research

Supports eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences workforce, and provides a bridge to investigators that have completed their research training and may need extra time to develop a larger research project grant application.
Due Dates: June 18 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-053


NEW
June 23 (Pre-app.) All Faculty Federal Prostate

Congressionally Directed Medical Research Programs (CDMRP)
Prostate Cancer Research Program (PCRP)
Idea Development Award  W81XWH-16-PCRP-IDA  

This award supports new ideas representing innovative approaches to prostate cancer research.  Research deemed innovative may represent a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities.  Research that is an incremental advance upon published data is not considered innovative.   This award also emphasizes potential short-term and long-term impact of the research project on prostate cancer research and/or patient care.
Due Dates: June 23 (Pre-application)
Invited Submissions:  Oct. 04 (OSR) I Oct. 06   (Sponsor)
Amount & Project Period: Established PIs:                      $600,000 (Direct Costs)
New Investigator Option:     $275,000 (Direct Costs)
Partnering PI Option:
Total for initiating & partnering PIs: $1,000,000 (Direct Costs)
Period of performance:       3 years
Eligibility: Established InvestigatorsIndependent investigators at or above the level of Assistant Professor (or equivalent);
partnering PI option supports synergistic partnerships among established investigators, structured for up to a total of 3 PIs.  New Investigators: must meet the following criteria:
     1. Freedom to pursue individual aims w/out formal
     mentorship;
     2. Not previously received a PCRP Idea Development Award;
     3. Either completed at least 3 years of postdoctoral training
     or fellowship (if never held an independent faculty
     position); or been in an independent faculty position for <5
     years.
Contact: Office of Sponsored Research (x6804)
Links: Program Announcement I https://eBRAP.org (Pre-app.)


NEW
June 23 (Pre-app.) All Faculty Ranks Federal See Below

Congressionally Directed Medical Research Programs (CDMRP)
Peer Reviewed Medical Research Program (PRMRP)

Due Dates June 23 (Pre-application)
Invited Submissions:  Oct. 17 (OSR) Ι Oct. 19 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: https://eBRAP.org (Pre-app.)
FY16 Peer Reviewed Medical Research Program (PRMRP)

Investigator-Initiated Research Award
W81XWH-16-PRMRP-IIRA

This award is designed to support research w/potential to yield highly impactful data that could lead to critical discoveries or major advancements. The PI must clearly articulate the project's potential immediate and long-range outcome(s)/product(s) (knowledge and/or materiel) and how they will impact a central critical problem or question.
Amount & Project Period: Single PI:                       $1,200,000 (Direct Costs)
Partnering PI Option: $1,500,000 (Direct Costs)
Performance Period:   3 years
Link: Program Announcement 
 

Technology/ Therapeutic Development Award
W81XWH-16-PRMRP-TTDA

This is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, in at least one of the Congressionally directed FY16 PRMRP Topic Areas. Applications must include relevant data that support the rationale for the proposed study.
Amount & Project Period: $3,000,000 (Direct Costs) - 3 years
Link: Program Announcement




NEW
June 23 All Ranks Non-federal Bavituximab

Phase I/II Clinical Trials and Correlative Trials of Bavituximab for Solid Tumors

The overall aim is to develop innovative studies to help determine the role of bavituximab in expanding efficacy and/or improving outcomes for patients treated with immunotherapy or with modalities that increase tumor antigenicity.  It is hoped that the concepts submitted in response to this RFP will prove useful in guiding further development of bavituximab.   Studies with correlative endpoints are encouraged.
Due Dates: June 21 (OSR) Ι June 23 (Sponsor)
Amount & Project Period: Phase I Studies & Single-Arm Phase II:     $300,000 - 2 years Correlative Studies:                                      $100,000 - 2 years Add $100,000 for multi-institutional studies.  Funding should not exceed $500,000 as itemized above.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: NCCN Investigator's Login


NEW
June 29 (Pre-app.) See Below Federal See Below

Congressionally Directed Medical Research Programs
Peer Reviewed Medical Research Program (PRMRP)
Due Dates: June 29 (Pre-application)
Invited Submissions:  Oct 24 (OSR) Ι Oct 26 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: https://eBRAP.org (Pre-app.)
FY16 Peer Reviewed Medical Research Program (PRMRP)
Focused Program Award
W81XWH-16-PRMRP-FPA

Applications must describe a unifying, overarching challenge to be addressed by a set of research projects. The overarching challenge must be relevant to a critical problem or question in the field of research and/or patient care in at least one of the FY16 PRMRP Topic Areas.  Applications shall include multiple, distinct research projects led by individual project leaders that address complementary aspects of the overarching challenge. Projects must be interrelated and synergistic, and advance a solution beyond what would be possible through individual efforts.
Amount & Project Period: $10,000,000 (Total) - 4 years
Eligibility: PI must be at or above Full Professor (or equiv.) level;
PI must commit at least of 20% effort to this award
Project leaders must be at or above Asst. Professor (or equiv.) level.
Link: Program Announcement 
 

Clinical Trial Award
W81XWH-16-PRMRP-CTA

Supports rapid implementation of clinical trials w/potential to have a significant impact on a disease or condition addressed in at least one of the congressionally directed FY16 PRMRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations.
Amount & Project Period: Application budget not restricted, but must be justified & appropriate to scope of proposed clinical trial - 4 years
Eligibility: Assistant Professor (or equiv.) level or above
Link: Program Announcement


NEW
June 30 (LOI) All Faculty Ranks Non-federal Pediatric Cancers

Alex's Lemonade Stand Foundation
Familial RUNX1

ALSF and The Babich Family Foundation have partnered to raise awareness and accelerate research around familial RUNX1 disorders.
Due Dates: June 30 (Letter of Intent)
Invited Submissions:  Sept. 29 (OSR) I Oct. 03 (Sponsor)
Eligibility: Must have faculty appointment
May be MD, DO, PhD, or MD/PhD
Must have record of publication & funding productivity in the last 5 years
Multiple investigator applications that bring together pairs or teams of researches with complementary expertise are encouraged
Contact: Office of Sponsored Research (x6804)   
 

2016 Familial RUNX1 Research Grant

The purpose is to fund research that will develop strategies leading to development of therapies for prevention of the transition from pre-leukemia to leukemia for patients with the familial RUNX1 disorder. Projects should focus on familial RUNX1 disorder rather than acquired RUNX1 mutations seen during the evolution of AML.
Amount & Project Period: $250,000 - 2 years
 Link: Guidelines I Grant Guidelines & Submissions
 

2016 Familial RUNX1 Patient Samples Grant

The purpose is to increase understanding of the disease pathogenesis of familial RUNX1 disorders by facilitating correlative analyses of longitudinal patient samples and outcome data. Identification of sources for the collection and annotation of samples from patients with familial RUNX1 disorders will be foundational to building the familial RUNX1 disorder research program.  Projects should focus on familial RUNX1 disorder rather than acquired RUNX1 mutations seen during the evolution of AML
Amount & Project Period: Up to $250,000/yr.  - 2 years
Link: Guidelines I Grant Guidelines & Submissions


June 30 All Faculty Non-federal Children's Leukemia

Children's Leukemia Research Association (CLRA)
Research Grants

These research grants are for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.
Due Dates: June 28 (OSR) Ι June 30 (Sponsor)
Amount & Project Period: $30,000 - 1 year
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Application

NEW
June 30 Graduate Students Non-federal Career Development

James S. McDonnell Foundation
2016 Postdoctoral Fellowship in Studying Complex Systems

The JSMF Fellowship is designed to provide students with an opportunity to seek potential postdoctoral research opportunities on the basis of the student's interest and desire to obtain additional skills and experience that will further their pursuit of careers in complex systems science.
Due Dates: Jul. 18 (OSR) Ι Jul. 20 (Sponsor)
Additional Due Date: Feb. 23, 2017
Amount & Project Period: $200,000 (TOTAL) - 2 to 3 years
Eligibility: Applicants may not already have a Ph.D. or expect to receive one before submission deadline.
Applicants should have theoretical and/or experimental training in Complex Systems Science.
Applicants should not have already identified a postdoctoral position and postdoctoral research mentor.
Applicants should understand that if a letter of intent to fund is received, it is unlikely that an application to remain at the same institution will be approved.
Candidates from any country are eligible
Contact: Office of Sponsored Research (x6804)
Link: Guidelines
R03 NIH
NCI is a participating Institute

NEW
June 30 (LOI) Junior Faculty Federal Tobacco Regulatory Science

Tobacco Regulatory Science Small Grant Program for New Investigators

Applicants are encouraged to conduct projects that ultimately have potential to inform regulations on tobacco product manufacturing, distribution, and marketing.  Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31.
Due Dates: June 30 (Letter of Intent)
Applications due: Jul. 18 (OSR) Ι Jul. 20 (Sponsor)
Amount & Project Period: $150,000 (Direct Costs) - 2 years
Eligibility: Only New Investigators are eligible.
Excluded from consideration are
individuals who have received the following from any NIH Institute or Center:
1.  Pathway to Independence Award-Research Phase (R00)
2.  Small Grant (R03) support in Tobacco Regulatory Science  
3.  Exploratory/Developmental Grant (R21) in Tobacco
     Regulatory Science
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-OD-15-004


NEW
July 01 Established Investigators Non-federal Pancreatic

Pancreatic Cancer Action Network (PANCAN)
Precision Promise Clinical Trial Consortium

The mission of Precision Promise is to transform outcomes for all pancreatic cancer patients. Precision Promise has three components: a Coordinating Center, a Translational Research Grants Program and a Clinical Trial Consortium. The purpose of this RFA is to constitute the Precision Promise U.S. Clinical Trial Consortium which will start with 10 U.S. clinical sites, but it is envisioned to expand to additional sites in the U.S. and globally and to incorporate just-in-time trial initiation in the future.
Due Dates: June 29 (OSR) Ι July 01(Sponsor)
Amount & Project Period: One-time upfront $15,000 to establish each CTC site; $100,000/yr. to support Master Protocol and general CTC activities;
20% for indirect costs.
Contracts are renewable on a yearly basis and dependent on reaching specified milestones of patient enrollment and data quality.
Eligibility: Contact PI must be an independent researcher w/a doctoral   degree (incl. PhD, MD, DO, PharmD or equiv.) in biomedical sciences or field applicable to health science research.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Guidelines and Instructions Ι proposalCENTRAL

NEW
July 01 All Ranks Non-federal Lung

Lung Cancer Research Foundation
Grant Program

This program provides funding for innovative research focused on the prevention, diagnosis, treatment and cure of lung cancer.  The Foundation encourages applications for projects investigating a wide variety of research topics, including:
    1. Prevention and screening for early detection
    2. Identification of new biomarkers and the development of targeted therapies
    3. The development of next-generation chemotherapeutic agents
    4. Supportive measures for people with lung cancer and their families Quality of care and
     outcomes research.
Due Dates: June 29 (OSR) Ι Jul. 01 (Sponsor)
Amount & Project Period: $150,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Guidelines


July 01 Postdocs Non-federal Career Development

The Helen Hay Whitney Foundation
Research Fellowship

Grants financial support of sufficient duration to help further the careers of young men and women engaged in basic biological or medical research. 
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: Yr. 01:  $51,000 (Stipend) - $1,500 (Allowance)
Yr. 02:  $52,000 (Stipend) - $1,500 (Allowance)
Yr. 03:  $53,000 (Stipend) - $1,500  (Allowance)
Eligibility: Hold, or be in final stages of obtaining Ph.D., M.D., or equivalent;
Have <1 year of postdoctoral research experience as of due date and have received a PhD <2 years before due date, or M.D. degree <3 years before due date
Contact: Office of Sponsored Research (X6804)
Link: Research Fellowships


July 01 Junior Clinical Faculty Non-federal Career Development

Damon Runyon Cancer Research Foundation
Rachleff Innovation Award

The goal is to fund high-risk/high-reward research that lacks sufficient preliminary data to secure traditional funding.
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: $300,000 (Total) - 2 years
Note: Continued support for years 3 and 4 will be granted to those awardees who demonstrate progress on their proposed research during years 1 and 2.
Eligibility: Applicants must belong to 1 of the following:
Tenure-track Assistant Professors w/in first 4 years of initial Asst. Professor appt. (Cut-off date: July 1, 2012.)
Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding an MD and pursuing a period of independent research before taking a tenure-track faculty position.  Such individuals must have an exceptional record of research accomplishment, dedicated laboratory space and support of their institution.
Note: Research Assistant Professors, Research Associate Professors, Research Scientists and Postdoctoral Fellows are not eligible. 
Applicants are expected to commit a minimum of 80% effort to research
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines

July 01 All Ranks Non-federal Cutaneous

American Society for Dermatologic Surgery
Cutting Edge Research Grant Program (CERG)  

Submission of well-conceived research projects is encouraged.  Specifically encouraged are proposals in the areas of depth of training, scope of practice, safety and efficacy as well as research with specific relevance in:  Cosmetic medicine and surgery; Core surgical procedures and techniques; Cutaneous oncology; and  new technologies.
Due Dates: June 29 (OSR) Ι Jul. 01(Sponsor)
Amount & Project Period: $20,000 - 1 year
Eligibility: All Ranks;
PD/PI must be ASDS member
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι 2016 Application Site




July 01 All Ranks Non-Federal Clinical Oncology

The Hope Foundation
Early Exploration and Development (SEED) Fund

To encourage preliminary research that will translate to clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN).  Awards may assist investigators with projects that support the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology.
Due Dates: June. 29 (OSR) Ι Jul. 01. 5:00pm, ET (Sponsor)
Additional Due Date:
  December 01
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Any SWOG investigator
Contact: Office of Sponsored Research (x6804)
RFA Link: Research & Funding Ι Announcement
U01 NHGRI
NCI is a participating institute

NEW
July 06 (LOI) All Ranks Federal Clinical Genome Sequencing

Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites with Enhanced Diversity

The purpose is to establish Clinical Sites with Enhanced Diversity that collectively encompass a broad spectrum of healthcare settings and serve ancestrally and socioeconomically diverse patients with a wide range of clinical conditions, to: 1) define, generate and analyze evidence regarding the clinical utility of genome sequencing; 2) research critical interactions among patients, family members, health practitioners, and clinical laboratories that influence implementation of clinical genome sequencing; and 3) identify and address real-world barriers to integrating genomic, clinical, and healthcare utilization data within a healthcare system to build a shared evidence base for clinical decision-making. Applicants are expected to recruit a minimum of 60% of patients who come from racial or ethnic minority populations, underserved populations, or populations who experience poorer medical outcomes.  In contrast, applicants to the companion RFA HG-16-010 are expected to recruit a minimum of 25% of such patients.
Due Dates: Jul. 06 (Letter of Intent)
Applications Due:  Aug. 03 (OSR) | Aug. 05 (Sponsor)
Amount & Project Period: $2,500,000/yr. (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-HG-16-011
Companion RFAs: RFA-HG-16-010 (U01) I RFA-HG-16-012, (U24)


NEW
July 07 (Pre-app) See Below Federal Prostate (Career Development)

Congressionally Directed Medical Research Programs
Prostate Cancer Research Program (PCRP)

Due Dates: Jul. 07 (Pre-application)
Applications Due: Jul. 19 (OSR) Ι Jul. 21 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Links: FY16 Prostate Cancer Research Program (PCRP)
https://eBRAP.org (Pre-app.)
 

Early Investigator Research Award
W81XWH-16-PCRP-EIRA

This award supports prostate cancer-focused research opportunities for individuals in the early stages of their careers, under the guidance of a designated Mentor, and allows young investigators to develop a research project, investigate a problem or question in prostate cancer research, and further their intellectual development as a prostate cancer researcher of the future.
Amount & Project Period: Pre-doc PhD & M.D./PhD:  $60,000 (Direct costs)
Post-doc MD or PhD:        $125,000 (Direct Costs)
Period of performance:       2 years
Eligibility: By March 31, 2017:
Pre-doctoral Ph.D. PIs:  Must be enrolled full-time in an accredited doctoral program and must have completed all pre-dissertation requirements
Postdoctoral Ph.D. or M.D. PIs:  Must have successfully defended doctoral thesis or possess M.D. degree, & have <3 years of postdoctoral research experience (excluding clinical residency or clinical fellowship training) and be involved in an accredited training or residency program
Link: Program Announcement
 

Physician Research Award
W81XWH-16-PCRP-PRA

The Physician Research Award supports a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research.   The scientific rationale and experimental methodology should demonstrate in-depth analysis of the research problem. The feasibility of the research design and methods should be well defined, and a clear plan should be articulated as to how proposed goals can be achieved. Inclusion of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required.
Amount & Project Period: $520,000 (Direct Costs) - 4 years
Eligibility: At the time of application submission, the PI must be either: 
     a) In the last year of an accredited medical residency or   
     medical fellowship program; or
     b) W/in 3 years of having initiated an appointment as
     Instructor, Assistant Professor, or equivalent
40% Protected time for research is required
Link: Program Announcement


NEW
July 07 (Pre-app.) All Ranks Federal Discovery/Pilot Projects

Congressionally Directed Medical Research Programs
Peer Reviewed Medical Research Program (PRMRP)
Discovery Award  
W81XWH-16-PRMRP-DA

The intent is to support innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. Studies supported are expected to lay groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on a sound scientific rationale and study design.  Research relevant to one or more FY16 PRMRP Topic Areas may be considered for funding.
Due Dates: July 7 (Pre-application)
Invited Submissions:  Jul. 19 (OSR) | Jul. 21 (Sponsor)
Amount & Project Period: $200,000 (Direct Costs) - 18 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Program Announcement  Ι https://eBRAP.org (Pre-app.)


NEW
July 08 (LOI) All Faculty Ranks Non-federal Radiation

Radiation Oncology Institute (ROI)
Leveraging Big Data to Optimize Quality Assurance and Patient Care Improvement Initiatives  

This RFP seeks proposals addressing the highest impact research questions for the field of radiation oncology.  Focus on one or several prevalent cancers is encouraged, however, any proposal that would lead to important research utilizing big data to improve quality in radiation therapy is sought.  Special consideration given to proposals w/emphasis on identifying multidisciplinary data sources from all sectors that participate in providing care for cancer patients with radiation in order to develop Quality Assessment and Improvement methods that span all care collaborators. To this end, multidisciplinary teams composed of physicists, dosimetrists, doctors, nurses, allied medical personnel and clerical employees are highly encouraged.
Due Dates: July 08 (Letter of Intent)
Invited Submissions:  Sept. 14 (OSR) Ι Sept. 16(Sponsor)
Amount & Project Period: $100,000/yr. (TOTAL) - 2 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Guidelines and Instructions Ι proposalCENTRAL


NEW
July 13 (LOI) See Below Non-federal Psychosocial/Pediatric

Alex's Lemonade Stand Foundation (ALSF)
2016 Psychosocial Grants

Due Dates: July 13 (Letter of Intent)
Invited Applications:  Oct. 12 (OSR) Ι Oct. 14 (Sponsor)
Contact: Office of Sponsored Research (x6804)
 Links: Guidelines I Grant Guidelines & Submissions
 

Launch Grants

 Will support studies that aim to explain and/or improve psychosocial outcomes of those affected by childhood cancer.
Amount & Project Period: $100,000 - 2 years
Eligibility: W/in 7 years of obtaining terminal degree
 

Family Impact Grants

 Will support studies that aim to explain and/or improve psychosocial outcomes of those affected by childhood cancer.
Amount & Project Period: $300,000 - 3 years
Eligibility: Established Investigators
R44 NCI

NEW
July 13 See Below Federal Commercialization

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics and Prognostics Toward Commercialization

Additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency.  Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and/or in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. The purpose is to facilitate transition of SBIR or STTR Phase II projects to the commercialization stage.
Due Dates: Jul. 11 (OSR) Ι Jul. 13 (Sponsor)
Amount & Project Period: $1,000,000/yr.  (Total) - 3 years
Eligibility: Organized for profit, w/place of business in the U.S.
Has (including affiliates), no more than 500 employees.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-16-008


NEW
July 18 (Pre-app.) See Below Federal Neurofibromatosis

Congressionally Directed Medical Research Programs
Neurofibromatosis Research Program (NFRP)

Due Dates: Jul. 18 (Pre-application)
Invited Submissions:  Jul. 28 (OSR) Ι Aug. 01  (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: FY16 Neurofibromatosis Research Program (NFRP) https://eBRAP.org (Pre-app.)
 

Clinical Trial Award
W81XWH-16-NFRP-CTA

Supports research having potential for a major impact on treatment or management of NF.  Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies.  Proposed projects may range from small proof-of-concept (i.e., pilot, first in human, or Phase 0) trials to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations.
Amount & Project Period: $900,000 (Direct Costs) - 4 years
Eligibility: At or above Assistant Professor (or equiv.) level
Link: Program Announcement
 

Exploration - Hypothesis Development Award
W81XWH-16-NFRP-EHDA

Supports initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in NF research. Studies are expected to lay groundwork for future avenues of scientific investigation. The proposed project should include a well formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is encouraged, but not required.
Amount & Project Period: $100,000 (Direct Costs) - 2 years 
Eligibility: All Ranks
Link: Program Announcement
 

Investigator-Initiated Research Award
W81XWH-16-NFRP-IIRA

Supports highly rigorous, high-impact research projects having potential to make an important contribution to NF research and/or patient care. Projects may focus on any phase of research, excluding clinical trials. Applications must include preliminary and/or published data that are relevant to NF and the proposed project.  
Amount & Project Period: Single PI:    $525 (Direct Costs) - 3 years
PI & OQC:  $575,000 (Direct Costs) - 3 years
Eligibility: At or above Assistant Professor (or equiv.) level
OQC must be at or above Asst. Professor level (or equiv.) and must commit at least 10% effort throughout the duration of the award.
Link: Program Announcement
 

New Investigator Award
W81XWH-16-NFRP-NIA

Supports continued development of promising independent investigators and/or the transition of established investigators from other research fields into a career in the field of NF research. Projects may focus on any phase of research, excluding clinical trials. Applications must include preliminary and/or published data that are relevant to NF and the proposed project.
Amount & Project Period: $450,000 (Direct Costs) - 3 years
Eligibility: PIs must be either:
Independent investigators at or below Asst. Professor (or equiv.); OR
Established independent investigator in area other than NF at or above Asst. Professor seeking to transition to a career in NF Must not have received >$300,000 (total direct costs) for previous or concurrent NF research as PI of 1 or more Federally funded, non-mentored peer reviewed grants;
PIs must not have received a New Investigator Award previously from any program w/in CDMRP;
PIs must commit at least 10% effort on proposed NF project
Link: Program Announcement
K01 NIH
NCI is a participating Institute

NEW
August 01 All Ranks Federal Career Development

BD2K Mentored Career Development Award in Biomedical Big Data Science for Clinicians and Doctorally Prepared Scientists

This FOA solicits applications for a mentored career development award in the area of Big Data Science. The aim of the initiative is to support additional training of scientists who will gain the knowledge and skills necessary to be independent researchers as well as to work in a team environment to develop new Big Data technologies, methods, and tools applicable to basic and clinical research.
Due Dates: Jul. 28 (OSR) Ι Aug. 01 (Sponsor)
Amount & Project Period: Up to $185,100/yr. for  salary of award recipient
$40,000  per year toward research development costs
Award Duration:  4 years
Eligibility: Candidates must have a research or health-professional doctoral degree or equiv.
Intended for research-oriented investigators at any level of experience, from the postdoc to mid-career and senior level faculty, who have shown clear evidence of productivity and research excellence in the field of their training, and who would like to expand their research capability through a mentored career development experience.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-ES-16-002

August 05 All Ranks Non-federal Mesothelioma

The Meso Foundation (formerly known as MARF)
Mesothelioma Research Funding  

Proposed projects may relate to benchwork, translational or clinical research not presently funded.  Encouraged projects include, but are not limited to:
    1. Strategies for early detection and prevention of mesothelioma;
    2. Definition of targetable differences between normal and transformed mesothelium and
    development of novel strategies for treatment taking advantage of these targets;
    3. Determination of clinical/molecular determinants for prognosis
    4. Therapeutic intervention, including but not limited to:    
        a.   Immune Response Targeted Therapy
        b.   Novel chemotherapeutic compounds
        c.    Novel radiation or surgical techniques
Due Dates: Aug.03 (OSR) Ι Aug.05 (Sponsor)
Amount & Project Period: Up to $50,000/yr. - 2 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines


NEW
August 12 Established Investigators Non-federal Gastric

American Gastroenterological Association
Robert & Sally Funderburg Research Award in Gastric Cancer

To support the research of an established investigator working on novel approaches to gastric cancer,  including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in the diagnosis or treatment of gastric carcinoma.
Due Dates: August 10 (OSR) Ι August 12 (Sponsor)
Amount & Project Period: $100,000 - 2 years
Eligibility: Established independent investigator in gastric biology
AGA membership required at time of submission
Contact: Office of Sponsored Research (x6804)
Link: Guidelines


NEW
2016 Round 2
August 15 (Pre-prop.) All Ranks Non-federal Fanconi Anemia (FA)

Fanconi Anemia Research Fund, Inc.
Research Grants

Grants for research that focuses on rapid discovery and development of therapies or strategies that treat, control, or cure FA.   There is particular interest in supporting interdisciplinary and translational research efforts effectively addressing 1 or more of the following:
     1. Understand how alteration of the FA genes and their products lead to the clinical
     manifestations of FA.
     2. Determine causes of bone marrow failure, myelodysplasia and leukemia in individuals
     with FA, and to develop strategies to prevent, treat, and cure these disorders.
     3. Define the pathogenesis of FA-associated cancers, and to develop strategies for
     prevention, early detection, treatment and cure.
     4. Identify practical and proactive management strategies that families and persons with
     FA can use to maintain a high quality of life.
     5. Support creation of shared resources, databases, and technologies for the international
     FA research community.
Due Dates: August 15 (Pre-proposal)
Invited Applications: Oct. 28 (OSR) Ι Nov. 01 (Sponsor)
Amount & Project Period: $150,000-$175,000 (Total) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Grant Applications Ι Fanconi Anemia Research Fund, Inc.

NEW
August 15 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Fellowship Award

 All theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention are encouraged for this fellowship.
Due Dates: Aug. 12 (OSR) Ι Aug. 15 (Sponsor)
Completed applications and USB flash drives must be in sponsor's office by 4:00 pm (ET) on the deadline - NOT postmarked by that date.
Amount & Project Period: Funding is comprised of a Stipend ($50,000 Level 1 and $60,000 Level 2) and Expense Allowance ($2,000). -  4 years
Note:  Physician-scientists who have completed their residencies and clinical training and are board eligible in the United States will receive Level 2 funding
Eligibility: For degrees conferred between October 15, 2015 and August 15, 2016.
Contact: Office of Sponsored Research (x6071)
Links: Overview Ι Damon Runyon Cancer Research Foundation


NEW
August 26 Postdocs/Junior Faculty Non-federal Career Development

American Gastroenterological Association
Research Scholar Award

 This award enables young investigators, instructors, research associates or equivalents to develop independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research.
Due Dates: Aug. 24 (OSR) Ι August 26 (Sponsor)
Amount & Project Period: $270,000 (Total) - 3 years
Eligibility: Must hold a full-time faculty position by July 1, 2017;
MD applicants: no more than 7 years shall have elapsed following completion of clinical training (GI fellowship or its equivalent) and start date of this award.
PhD applicants: no more than 7 years shall have elapsed following award of PhD and start date of this award.
Contact: Office of Sponsored Research (x6804)
Links: Guidelines Ι American Gastroenterological Association
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology
Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org